首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   168705篇
  免费   31887篇
  国内免费   2470篇
耳鼻咽喉   5376篇
儿科学   5717篇
妇产科学   2573篇
基础医学   5267篇
口腔科学   2036篇
临床医学   27701篇
内科学   51461篇
皮肤病学   7673篇
神经病学   16193篇
特种医学   7175篇
外科学   44096篇
综合类   307篇
现状与发展   72篇
预防医学   7596篇
眼科学   3593篇
药学   2212篇
中国医学   35篇
肿瘤学   13979篇
  2024年   688篇
  2023年   4853篇
  2022年   1348篇
  2021年   3317篇
  2020年   6168篇
  2019年   2311篇
  2018年   7640篇
  2017年   7486篇
  2016年   8642篇
  2015年   8617篇
  2014年   15812篇
  2013年   16011篇
  2012年   6144篇
  2011年   6188篇
  2010年   10798篇
  2009年   14645篇
  2008年   6504篇
  2007年   4725篇
  2006年   7233篇
  2005年   4590篇
  2004年   3837篇
  2003年   2796篇
  2002年   2917篇
  2001年   4583篇
  2000年   3785篇
  1999年   3925篇
  1998年   3904篇
  1997年   3681篇
  1996年   3568篇
  1995年   3368篇
  1994年   2072篇
  1993年   1695篇
  1992年   1866篇
  1991年   1836篇
  1990年   1442篇
  1989年   1653篇
  1988年   1411篇
  1987年   1190篇
  1986年   1258篇
  1985年   1068篇
  1984年   816篇
  1983年   690篇
  1982年   594篇
  1981年   477篇
  1980年   434篇
  1979年   456篇
  1978年   442篇
  1977年   484篇
  1975年   362篇
  1972年   376篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
122.
PURPOSE: The aim of this study is (1) to develop a new method of risk classification for clinically localized prostate cancer; (2) to examine it in terms of compatibility with existing data such as nomograms; and (3) to compare it with existing risk-grouping methods. MATERIAL AND METHODS: The new grading system introduced here consists of three factors. The first is a prostate-specific antigen (PSA) of 4.1-10.0 ng/ml (score 0), 10.1-20.0 ng/ml (score 1), and >20.0 ng/ml (score 2). The second is a Gleason score (GS) of 6 (score 0), 7 (score 1), and 8-10 (score 2). The third is T classifications (UICC 2002) of T1c-T2a (score 0), T2b-T2c (score 1), and T3a (score 2). The sum of the three scores was named Prostate Risk Index (PRIX). Then, the compatibility of PRIX with the Partin Table, Kattan Nomogram, and Roach's formula was examined. At the same time, PRIX was compared with D'Amico, the National Comprehensive Cancer Network (NCCN), and Seattle classifications. RESULTS: PRIX 0 corresponded to 1-2% of pathologic lymph node involvement (pLN+) according to the Partin Table; PRIX 1 to 3-4%; PRIX 2 to 7-10%; PRIX 3 to 14-18%; PRIX 4 to 24-29%; PRIX 5 to 32-37%; and PRIX 6 to 42%. PRIX well separated the risks with relatively narrow ranges of probability, while D'Amico, NCCN, and Seattle classifications generally gave wide ranges especially for high-risk groups, both in the Partin Table and Kattan Nomogram. Roach's formula sometimes overestimated the risk compared to the Partin Table. CONCLUSION: PRIX fully corresponded to the Partin Table in terms of pLN+, and corresponded to the other nomograms better than any existing risk-grouping method. PRIX may thus function as a prognostic factor or contribute to patient selection in clinically localized prostate cancer.  相似文献   
123.
Four Chinese patients (2 boys, 2 girls), ages 4–9 years, who had episodes of perception error of body schema and objects are reported. The metamorphopsia, which had been named Alice in Wonderland syndrome, is the major presentation. All of them were proved to have acute Epstein-Barr virus infection, as documented by positive heterophil antibody test and/or positive IgM antibody to Epstein-Barr virus capsid antigen. The duration of the perception disorder ranged from 1 week to 3 months. We believe that any young child presenting with Alice in Wonderland syndrome should undergo examination for Epstein-Barr virus infection; complete recovery from the disorder can be expected.  相似文献   
124.
125.
126.
127.
128.
The red eye     
A red eye is a cardinal sign of ocular inflammation. Most cases are benign and can be managed by the primary care provider. The key is recognizing cases requiring ophthalmological consultation by differentiating between ciliary and conjunctival injection. Ciliary injection indicates inflammation of the cornea, iris, or ciliary body, whereas conjunctival injection mainly affects the posterior conjunctival blood vessels. The author has stated that he does not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The author also does not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.  相似文献   
129.
130.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号